A detailed history of Covestor LTD transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Covestor LTD holds 192 shares of DNA stock, worth $63. This represents 0.0% of its overall portfolio holdings.

Number of Shares
192
Previous 160 20.0%
Holding current value
$63
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$1.06 - $1.67 $33 - $53
32 Added 20.0%
192 $0
Q4 2023

Feb 09, 2024

SELL
$1.26 - $1.79 $2 - $3
-2 Reduced 1.23%
160 $0
Q3 2023

Nov 13, 2023

SELL
$1.61 - $2.54 $106 - $167
-66 Reduced 28.95%
162 $0
Q2 2023

Aug 11, 2023

BUY
$1.14 - $1.95 $119 - $204
105 Added 85.37%
228 $0
Q1 2023

May 15, 2023

BUY
$1.2 - $2.19 $19 - $35
16 Added 14.95%
123 $0
Q4 2022

Feb 13, 2023

BUY
$1.63 - $3.52 $52 - $112
32 Added 42.67%
107 $0
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $54 - $280
75 New
75 $0

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $425M
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.